TCRXNasdaq GM

TScan Therapeutics, Inc.

0.79−0.66%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tier
Alert levelinsufficient_liquidity

Tier and alert level are a summary. Unlock TCRX to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

−3.79%, downReturn · 1w
+3.35%, upReturn · 1m
−25.82%, downReturn · 3m
−58.23%, downReturn · 1y
−69.12%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 47.

RSI (14)47.22Neutral
MACD / signal-0.02 / -0.03, favorable readingAbove signal line
SMA 500.88, caution readingPrice below
SMA 2001.02, caution readingPrice below
EMA 200.80, caution readingPrice below
ADX (14)11.85Rangebound
+DI / −DI16.19 / 15.05+DI leading
ATR (14)0.04, flagged reading5.1% of price — elevated daily swings
Stochastic %K54.33Mid-range
Bollinger bands (20)0.72 – 0.82Inside bands
ROC (10)2.15, favorable readingPositive over 10 sessions
Trend / momentum impulseBoth rising, favorable impulse readingTrend and momentum agree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking TCRX reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock TCRX: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get TCRX + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock TCRX